Author： Wiggins Phillip
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.2, 2004-02, pp. : 93-95
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pharma industry less than healthy
Inpharma, Vol. 1, Iss. 1627, 2008-01 ,pp. :
Access to resources
Recommend
Pharma-sponsored DM: where to now?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 297, 2001-01 ,pp. :
Much, Much More Important than That
Addiction Research and Theory, Vol. 11, Iss. 5, 2003-01 ,pp. :
Valsartan: More Than a Decade of Experience
Drugs, Vol. 69, Iss. 17, 2009-12 ,pp. :
A dollar in, more than a dollar back
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 528, 2007-01 ,pp. :